Literature DB >> 30103833

The epidemiological impact and significance of carbapenem resistance in Pseudomonas aeruginosa bloodstream infections: a matched case-case-control analysis.

Tzach Aviv1, Tsillia Lazarovitch2, David Katz3, Ronit Zaidenstein4, Mor Dadon4, Chen Daniel4, Ruthy Tal-Jasper1, Keith S Kaye5, Dror Marchaim1.   

Abstract

A case-case-control investigation (N = 255 patients) explored the epidemiology of carbapenem-resistant Pseudomonas aeruginosa (CRPA). Recent exposure to carbapenems and a rapidly fatal condition should prompt practitioners to shorten delays in initiating appropriate therapy, which can adversely impact CRPA outcomes, as opposed to the isolated impact of the carbapenem resistance determinant.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30103833     DOI： 10.1017/ice.2018.181

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  3 in total

1.  Prevalence of colistin heteroresistance in carbapenem-resistant Pseudomonas aeruginosa and association with clinical outcomes in patients: an observational study.

Authors:  Jessica Howard-Anderson; Michelle Davis; Alexander M Page; Chris W Bower; Gillian Smith; Jesse T Jacob; Dan I Andersson; David S Weiss; Sarah W Satola
Journal:  J Antimicrob Chemother       Date:  2022-02-23       Impact factor: 5.758

2.  The Threat of Carbapenem-Resistant Gram-Negative Bacteria in Patients with Hematological Malignancies: Unignorable Respiratory Non-Fermentative Bacteria-Derived Bloodstream Infections.

Authors:  Linli Lu; Cong Xu; Yishu Tang; Liwen Wang; Qian Cheng; Xin Chen; Jian Zhang; Ying Li; Han Xiao; Xin Li
Journal:  Infect Drug Resist       Date:  2022-06-04       Impact factor: 4.177

3.  Mortality in patients with carbapenem-resistant Pseudomonas aeruginosa with and without susceptibility to traditional antipseudomonal β-lactams.

Authors:  Jessica Howard-Anderson; Chris W Bower; Gillian Smith; Sarah W Satola; Jesse T Jacob
Journal:  JAC Antimicrob Resist       Date:  2021-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.